Hanbing Zou

681 total citations
21 papers, 572 citations indexed

About

Hanbing Zou is a scholar working on Molecular Biology, Epidemiology and Biomedical Engineering. According to data from OpenAlex, Hanbing Zou has authored 21 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Epidemiology and 4 papers in Biomedical Engineering. Recurrent topics in Hanbing Zou's work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Autophagy in Disease and Therapy (5 papers). Hanbing Zou is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Autophagy in Disease and Therapy (5 papers). Hanbing Zou collaborates with scholars based in China and United States. Hanbing Zou's co-authors include Xiaojing Chen, Peifeng Liu, Yuexia Xie, Yan Zhou, Hongmei Liu, Xianming Kong, Xue Zhao, Ding Ma, Qianyun Tang and Kai Sun and has published in prestigious journals such as Advanced Materials, PLoS ONE and Scientific Reports.

In The Last Decade

Hanbing Zou

21 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanbing Zou China	15	297	123	115	105	86	21	572
Wenyan Ren China	11	241 0.8×	149 1.2×	33 0.3×	38 0.4×	114 1.3×	16	536
You Hee Choi South Korea	16	634 2.1×	145 1.2×	40 0.3×	96 0.9×	39 0.5×	34	857
Da Li China	12	253 0.9×	163 1.3×	104 0.9×	118 1.1×	45 0.5×	33	728
Sharon L. Wong Australia	11	280 0.9×	41 0.3×	77 0.7×	32 0.3×	22 0.3×	21	603
Dongjun Luo China	8	274 0.9×	95 0.8×	62 0.5×	183 1.7×	62 0.7×	10	558
Seong‐Min Kwon South Korea	12	205 0.7×	58 0.5×	49 0.4×	57 0.5×	13 0.2×	14	423
Felix Boakye‐Agyeman United States	9	239 0.8×	31 0.3×	71 0.6×	95 0.9×	24 0.3×	15	491
Lu Tan China	14	356 1.2×	126 1.0×	23 0.2×	84 0.8×	21 0.2×	33	556
Linghao Zhao China	13	229 0.8×	57 0.5×	162 1.4×	172 1.6×	46 0.5×	27	564

Countries citing papers authored by Hanbing Zou

Since Specialization

Citations

This map shows the geographic impact of Hanbing Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanbing Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanbing Zou more than expected).

Fields of papers citing papers by Hanbing Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanbing Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanbing Zou. The network helps show where Hanbing Zou may publish in the future.

Co-authorship network of co-authors of Hanbing Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Hanbing Zou. A scholar is included among the top collaborators of Hanbing Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanbing Zou. Hanbing Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xinghui, Xiaojing Chen, Xiaojing Chen, et al.. (2025). An on‐Demand Oxygen Nano‐vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy. Advanced Materials. 37(9). e2409378–e2409378. 4 indexed citations

Wang, Xingang, Ming Shen, Yingying Sun, et al.. (2024). Ultrasound-triggered cascade reaction via MnO2-CpG nanoparticles for boosting pyroptosis-mediated cancer immunotherapy. Nano Today. 57. 102394–102394. 9 indexed citations

Xie, Yuexia, Lei Xu, Hanbing Zou, et al.. (2023). DNA Nanoclusters Combined with One‐Shot Radiotherapy Augment Cancer Immunotherapy Efficiency. Advanced Materials. 35(17). e2208546–e2208546. 28 indexed citations

Liu, Hongmei, Ding Ma, Jinpeng Chen, et al.. (2022). A targeted nanoplatform co-delivery of pooled siRNA and doxorubicin for reversing of multidrug resistance in breast cancer. Nano Research. 15(7). 6306–6314. 17 indexed citations

Li, Ye, Hongmei Liu, Fei Xin, et al.. (2021). Enhanced endosomal escape of dendrigraft poly-L-lysine polymers for the efficient gene therapy of breast cancer. Nano Research. 15(2). 1135–1144. 29 indexed citations

Liu, Hongmei, Chongyi Liu, Ye Li, et al.. (2021). Cancer Therapy: Nanoassemblies with Effective Serum Tolerance Capability Achieving Robust Gene Silencing Efficacy for Breast Cancer Gene Therapy (Adv. Mater. 7/2021). Advanced Materials. 33(7). 4 indexed citations

Zou, Hanbing. (2021). Analysis of Best Sampling Strategy in Credit Card Fraud Detection Using Machine Learning. 40–44. 5 indexed citations

Xie, Yuexia, Qianyun Tang, Hanbing Zou, et al.. (2020). Iron Oxide Nanoparticles as Autophagy Intervention Agents Suppress Hepatoma Growth by Enhancing Tumoricidal Autophagy. Advanced Science. 7(16). 1903323–1903323. 46 indexed citations

Xie, Yuexia, Liangliang Wu, Xiaojing Chen, et al.. (2020). Author Correction: PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma. Scientific Reports. 10(1). 6913–6913. 1 indexed citations

10.

Ye, Ping, Yuanyuan Ye, Xiaojing Chen, et al.. (2020). Ultrasmall Fe₃O₄ nanoparticles induce S-phase arrest and inhibit cancer cells proliferation. Nanotechnology Reviews. 9(1). 61–69. 17 indexed citations

11.

Liu, Hongmei, Chongyi Liu, Ye Li, et al.. (2020). Nanoassemblies with Effective Serum Tolerance Capability Achieving Robust Gene Silencing Efficacy for Breast Cancer Gene Therapy. Advanced Materials. 33(7). e2003523–e2003523. 34 indexed citations

12.

Ma, Ding, Hongmei Liu, Peipei Zhao, et al.. (2020). Programing Assembling/Releasing Multifunctional miRNA Nanomedicine to Treat Prostate Cancer. ACS Applied Materials & Interfaces. 12(8). 9032–9040. 22 indexed citations

13.

Kong, Xianming, Yuexia Xie, Hanbing Zou, et al.. (2019). Potent anti-tumor immunostimulatory biocompatible nanohydrogel made from DNA. Nanoscale Research Letters. 14(1). 217–217. 12 indexed citations

14.

Xie, Yuexia, Liangliang Wu, Xiaojing Chen, et al.. (2017). PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma. Scientific Reports. 7(1). 46250–46250. 56 indexed citations

15.

Ye, Ping, Yu Kong, Xiaojing Chen, et al.. (2016). Fe3O4 nanoparticles and cryoablation enhance ice crystal formation to improve the efficiency of killing breast cancer cells. Oncotarget. 8(7). 11389–11399. 20 indexed citations

16.

Zhou, Yan, Yuanliang Zhang, Hanbing Zou, et al.. (2015). The multi-targeted tyrosine kinase inhibitor vandetanib plays a bifunctional role in non-small cell lung cancer cells. Scientific Reports. 5(1). 8629–8629. 22 indexed citations

17.

Ma, Yi, Yan Zhou, Longmei Xu, et al.. (2015). Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment. Cancer Letters. 361(1). 128–136. 55 indexed citations

18.

Li, Shao, et al.. (2015). Changes in levels of IL-9, IL-17, IFN-γ, dendritic cell numbers and TLR expression in peripheral blood in asthmatic children with Mycoplasma pneumoniae infection.. PubMed. 8(5). 5263–72. 15 indexed citations

19.

Chen, Xiaojing, Kai Sun, Ning Cai, et al.. (2014). High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients. Scientific Reports. 4(1). 7481–7481. 129 indexed citations

20.

Ma, Yi, et al.. (2012). Consent for Use of Clinical Leftover Biosample: A Survey among Chinese Patients and the General Public. PLoS ONE. 7(4). e36050–e36050. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact